Cellid, COVID-19 vaccine Korean stock

업데이트됨
Bullish

Reasons
- Cup & handle formation
- Bounces on trendline
- Currently developing COVID-19 vaccine in Korea alongside other biotech products
- Korean government granted $30 mil to develop vaccines recently
액티브 트레이드
Prices pulled back from the initial trendline due to choppiness from falling KOSDAQ index. This was due to fears of economic shutdown from COVID-19 breakouts.

Still a go. It still has not announced a clinical trial for the COVID-19 vaccine but received money from the Korean government to develop one. If it is announced, then it is going to rocket.
액티브 트레이드
Space elevator~
거래청산: 스탑 닿음
Events didn't pan out as I had expected.

Too bad.
Technical IndicatorsTrend Analysis

또한 다음에서도:

면책사항